Skip to content

Coronavirus Special Report: What’s next for the surplus of hydroxychloroquine?

Bottles of hydroxychloroquine pills wait to be distributed in hospitals in San Salvador, El Salvador, on April 21.
Bottles of hydroxychloroquine pills wait to be distributed in hospitals in San Salvador, El Salvador, on April 21. (Yuri Cortez/AFP via Getty Images file photo)

In tonight’s podcast, we delve into the latest in health policy news: What will states that purchased the malaria drug hydroxychloroquine do with their supplies of the increasingly discredited COVID-19 treatment option? And what should we expect from Dr. Anthony Fauci’s Senate testimony next week? Also, Republican lawmakers reckon with oversight.

Recent Stories

Shooting cuts short Trump appearance at White House media gala

‘When the dealin’s done’  — Congressional Hits and Misses

Lawmakers buck calls to defund low-income heating program

DOJ drops investigation into Fed’s Powell

Photos of the week | April 17-23, 2026

Lutnick urges boost for trade enforcement at BIS